News
INGN
5.76
-0.86%
-0.05
Inogen Inc. Earnings Call Balances Growth and Caution
TipRanks · 1d ago
Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure Persists
NASDAQ · 3d ago
Should Investors Buy Inogen as Low Valuation Meets Execution Risk?
NASDAQ · 3d ago
Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut
NASDAQ · 4d ago
Weekly Report: what happened at INGN last week (0803-0807)?
Weekly Report · 4d ago
Inogen, Inc. (NASDAQ:INGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$12.67
Simply Wall St · 5d ago
Inogen (INGN) Stock Drops As Guidance Cut Clouds Margin Progress
Simply Wall St · 6d ago
Inogen (INGN) Has a New Rating from B. Riley Securities
TipRanks · 08/07 13:17
Inogen Q2 Sales $95.084M Miss $95.233M Estimate
Benzinga · 08/06 20:08
Here are the major earnings after the close Thursday
Seeking Alpha · 08/06 14:00
Weekly Report: what happened at INGN last week (0727-0731)?
Weekly Report · 08/03 09:14
Weekly Report: what happened at INGN last week (0720-0724)?
Weekly Report · 07/27 09:14
Weekly Report: what happened at INGN last week (0713-0717)?
Weekly Report · 07/20 09:14
Weekly Report: what happened at INGN last week (0706-0710)?
Weekly Report · 07/13 09:14
Weekly Report: what happened at INGN last week (0629-0703)?
Weekly Report · 07/06 09:15
Inogen Appoints New Chief Operating Officer for Growth
TipRanks · 07/01 20:36
Inogen appoints Andy Reding as chief operating officer
Seeking Alpha · 07/01 20:22
Inogen Appoints Reding to New COO Role
Dow Jones · 07/01 20:21
Inogen names Andy Reding COO
TipRanks · 07/01 20:10
*Inogen Names Andy Reding to Newly Created Role of Oper Chief, Effective July 6 >INGN
Dow Jones · 07/01 20:10
More
Webull provides a variety of real-time INGN stock news. You can receive the latest news about Inogen Inc through multiple platforms. This information may help you make smarter investment decisions.
About INGN
Inogen, Inc. is a global medical technology company offering respiratory products for use in the homecare setting. The Company partners with patients, prescribers, home medical equipment providers, and distributors to make its respiratory therapy products available. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators (POCs), used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. It also distributes the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure (CPAP) masks in the United States. Its proprietary Inogen One and Inogen Rove POC systems concentrate the air around the patient to offer a source of supplemental oxygen 24 hours a day, seven days a week with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available.